Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type

Figure 2

Overall survival (OS) and progression-free survival (PFS) according to CD30-positive vs. CD30-negative expression at diagnosis in patients with extranodal natural killer T-cell lymphomas, nasal type (ENKTL). Kaplan-Meier plots of OS (A) for all patients and PFS (B) for all patients; Kaplan-Meier plots of OS (C) and PFS (D) for subgroups with low International Prognostic Index (IPI) scores of 0–1; Kaplan–Meier plots of OS (E) and PFS (F) for subgroups with low Korean Prognostic Index (KPI) scores of 0–1.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us